Tranylcypromine in mind (Part I): Review of pharmacology
Authors:
Top Cited Papers
Open Access
- 1 August 2017
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 27 (8) , 697-713
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaNature Medicine, 2012
- Brain-Penetrant LSD1 Inhibitors Can Block Memory ConsolidationACS Chemical Neuroscience, 2011
- Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NETProceedings of the National Academy of Sciences, 2011
- The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive DisorderNeuropsychopharmacology, 2011
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedBritish Journal of Pharmacology, 2007
- Double-Blind Comparison of Moclobemide and Tranylcypromine in DepressionPharmacopsychiatry, 1993
- Effects of tranylcypromine enantiomers on monoamine uptake and release and imipramine bindingJournal of Neural Transmission, 1986
- Turnover rates of monoamine oxidases: Recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenolLife Sciences, 1972
- Arylcycloalkylamines. I. 2-PhenylcyclopropylamineJournal of the American Chemical Society, 1948